Please provide your email address to receive an email when new articles are posted on . Vitamin D insufficiency before chemotherapy associated with higher risk for peripheral neuropathy. Vitamin D ...

While there is currently no effective treatment for chemotherapy-induced peripheral neuropathy, one of the most common and severe adverse effects for patients who have undergone chemotherapy for ...

Clinical Utility of Tumor Next-Generation Sequencing Panel Testing to Inform Treatment Decisions for Patients With Advanced Solid Tumors in a Tertiary Care Center Postural sway during 30 seconds of ...

Exercise may improve CIPN symptoms in ovarian cancer patients, though evidence is limited. CIPN is linked to decreased physical function and quality of life, with no consensus on management. Some ...

Chemotherapy remains one of the most powerful tools in the fight against cancer, yet it often comes with significant ...

Please provide your email address to receive an email when new articles are posted on . Chemotherapy-induced peripheral neuropathy is a potentially debilitating, often persistent adverse event ...

Most patients receiving chemotherapy with taxanes or platinum salts develop pain and loss of sensitivity in their hands and feet—a severe side effect that can interfere with proper treatment.

A French-American research team discovered that the investigational compound Carba1 may prevent chemotherapy-induced peripheral neuropathy (CIPN) in preclinical models. According to a study published ...

Patients who had low levels of vitamin D before starting chemotherapy tended to have higher rates of chemotherapy-induced peripheral neuropathy, but more research is needed in this field. Patients who ...

Cryotherapy may reduce the occurrence of peripheral neuropathy in patients with breast cancer undergoing chemotherapy with paclitaxel and nab-paclitaxel, according to recent findings from an analysis.

Photobiomodulation, which uses low-level red infrared light, may reduce the severity of chemotherapy-induced peripheral neuropathy (CIPN) and increase mobility in patients with cancer, new research ...

TTHealthWatch is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for Johns Hopkins Medicine in Baltimore, and Rick Lange, MD, president of the Texas Tech ...